The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Intuitive Surgical Inc

Nasdaq: ISRG
Last

(U.S.) $512.15

Today's change-24.09 -4.49%
Updated February 8 12:54 PM EST. Delayed by at least 15 minutes.
 

Intuitive Surgical Inc

Nasdaq: ISRG
Last

(U.S.) $512.15

Today's change-24.09 -4.49%
Updated February 8 12:54 PM EST. Delayed by at least 15 minutes.

Intuitive Surgical Inc crosses below 125-day moving average

Intuitive Surgical Inc is sharply lower today, dropping (U.S.)$24.09 or 4.49% to (U.S.)$512.15 and crossing below its 125-day moving average. Over the last five days, shares have lost 5.71% and are down 6.23% for the last year to date. This security has outperformed the S&P 500 by 10.28% during the last year.

Key company metrics

  • Open(U.S.) $530.56
  • Previous close(U.S.) $536.24
  • High(U.S.) $530.56
  • Low(U.S.) $504.62
  • Bid / Ask(U.S.) $511.11 / (U.S.) $512.05
  • YTD % change-6.23%
  • Volume312,098
  • Average volume (10-day)412,978
  • Average volume (1-month)432,004
  • Average volume (3-month)368,944
  • 52-week range(U.S.) $447.00 to (U.S.) $580.00
  • Beta0.66
  • Trailing P/E33.03×
  • P/E 1 year forward25.94×
  • Forward PEG1.84×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $15.51
Updated February 8 12:54 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+24.69%

Based on its net profit margin of 24.69%, Intuitive Surgical Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.53%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue677590586532
Total other revenue--------
Total revenue677590586532
Gross profit459396387337
Total cost of revenue218194200195
Total operating expense431400412402
Selling / general / administrative160155163162
Research & development53514944
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income246190174130
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax252194178135
Income after tax19016713597
Income tax, total62264438
Net income19016713597
Total adjustments to net income--------
Net income before extra. items19016713597
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items19016713597
Inc. avail. to common incl. extra. items19016713597
Diluted net income19016713597
Dilution adjustment----0--
Diluted weighted average shares38383838
Diluted EPS excluding extraordinary itemsvalue per share4.974.403.562.57
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share4.974.403.562.57